IP Library Patent Application 10966064
Patent Application
App. No. 10/966,064

Combinatorial libraries of monomer domains

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/966,064
Abstract

Methods for identifying discrete monomer domains and immuno-domains with a desired property are provided. Methods for generating multimers from two or more selected discrete monomer domains are also provided, along with methods for identifying multimers possessing a desired property. Presentation systems are also provided which present the discrete monomer and/or immuno-domains, selected monomer and/or immuno-domains, multimers and/or selected multimers to allow their selection. Compositions, libraries and cells that express one or more library member, along with kits and integrated systems, are also included in the present invention.

Claims (154)

1 - 92 . (canceled)

93 . A product comprising at least two monomer domains, wherein at least one monomer domain is a non-naturally occurring monomer domain and the monomer domains bind calcium.

94 . The product of claim 93 , wherein more than one of the monomer domains is a non-naturally-occurring monomer domain.

95 . The product of claim 93 , wherein each of the monomer domains is a non-naturally-occurring monomer domain.

96 . The product of claim 93 , wherein each of the monomer domains binds calcium.

97 . The product of claim 93 , wherein at least one of the monomer domains is derived from an LDL-receptor class A domain.

98 . The product of claim 93 , wherein at least one of the monomer domains is derived from an EGF-like domain.

99 . The product of claim 93 , wherein at least one domain has a binding specificity for a blood factor.

100 . The product of claim 99 , wherein the blood factor is serum albumin.

101 . The product of claim 93 , wherein the monomer domains are separated by a linker.

102 . The product of claim 101 , wherein the linker is a peptide linker.

103 . The product of claim 102 , wherein the linker is between 4 to 12 amino acids long.

104 . The product of claim 93 , wherein the product comprises a first monomer domain that binds a first molecule and a second monomer domain that binds a second molecule.

105 . The product of claim 104 , wherein the first and second molecules are different.

106 . The product of claim 104 , wherein the first and second molecules are different copies of the same molecule.

107 . The product of claim 93 , wherein the product comprises two monomer domains, each monomer domain having a binding specificity for a binding site on a first molecule.

108 . The product of claim 107 , wherein each of the two monomer domains have a binding specificity for a different binding site on the first molecule.

109 . The product of claim 93 , wherein the monomer domains are between 25 and 500 amino acids.

110 . The product of claim 93 , wherein the monomer domains are between 25 and 50 amino acids.

111 . The product of claim 93 , wherein the monomer domains are between 30 and 100 amino acids.

112 . The product of claim 93 , wherein the product comprises at least three monomer domains.

113 . The product of claim 93 , wherein the product comprises four monomer domains.

114 . The product of claim 93 , wherein the monomer domains are derived from human monomer domains.

115 . The product of claim 93 , wherein a polypeptide comprises the at least two monomer domains.

116 . A product comprising at least 4 monomer domains, wherein at least one monomer domain is non-naturally occurring, and wherein:

a. each monomer domain is between 30-100 amino acids and each of the monomer domains comprise at least one disulfide linkage; or

b. each monomer domain is between 30-100 amino acids and is derived from an extracellular protein; or

c. each monomer domain is between 30-100 amino acids and binds to a protein target.

117 . The product of claim 116 , wherein each monomer domain is between 30-100 amino acids and each of the monomer domains comprise at least one disulfide linkage.

118 . The product of claim 116 , wherein each monomer domain is between 30-100 amino acids and is derived from an extracellular protein.

119 . The product of claim 116 , wherein each monomer domain is between 30-100 amino acids and binds to a protein target.

120 . The product of claim 116 , wherein the monomer domains are derived from human monomer domains.

121 . The product of claim 116 , wherein more than one of the monomer domains is a non-naturally-occurring monomer domain.

122 . The product of claim 116 , wherein each of the monomer domains is a non-naturally-occurring monomer domain.

123 . The product of claim 116 , wherein each of the monomer domains binds a metal ion.

124 . The product of claim 116 , wherein each of the monomer domains binds a calcium ion.

125 . The product of claim 116 , wherein at least one of the monomer domains is derived from an LDL-receptor class A domain.

126 . The product of claim 116 , wherein at least one of the monomer domains is derived from an EGF-like domain.

127 . The product of claim 116 , wherein at least one domain has a binding specificity for a blood factor.

128 . The product of claim 127 , wherein the blood factor is serum albumin.

129 . The product of claim 116 , wherein the monomer domains are separated by a linker.

130 . The product of claim 129 , wherein the monomer domains are separated by a peptide linker.

131 . The product of claim 130 , wherein the linker is between 4 to 12 amino acids long.

132 . The product of claim 116 , wherein the product comprises a first monomer domain that binds a first molecule and a second monomer domain that binds a second molecule.

133 . The product of claim 132 , wherein the first and second molecules are different.

134 . The product of claim 133 , wherein the first and second molecules are different copies of the same molecule.

135 . The product of claim 116 , wherein the product comprises two monomer domains, each monomer domain having a binding specificity for a site on a first molecule.

136 . The product of claim 135 , wherein each of the two monomer domains have a binding specificity for a different binding site on the first molecule.

137 . The product of claim 116 , wherein a polypeptide comprises the at least four monomer domains.

138 . A product comprising at least 4 monomer domains, wherein at least one monomer domain is non-naturally occurring, and wherein:

a. each monomer domain is between 35-100 amino acids; or

b. each domain comprises at least one disulfide bond and is derived from a human protein and/or an extracellular protein.

139 . The product of claim 138 , wherein each monomer domain is between 35-100 amino acids.

140 . The product of claim 138 , wherein each domain comprises at least one disulfide bond and is derived from a human protein and/or an extracellular protein.

141 . The product of claim 138 , wherein the monomer domains are derived from human monomer domains.

142 . The product of claim 138 , wherein more than one of the monomer domains is a non-naturally-occurring monomer domain.

143 . The product of claim 138 , wherein each of the monomer domains is a non-naturally-occurring monomer domain.

144 . The product of claim 138 , wherein each of the monomer domains binds a metal ion.

145 . The product of claim 138 , wherein each of the monomer domains binds calcium.

146 . The product of claim 138 , wherein at least one of the monomer domains is derived from an LDL-receptor class A domain.

147 . The product of claim 138 , wherein at least one of the monomer domains is derived from an EGF-like domain.

148 . The product of claim 138 , wherein at least one domain has a binding specificity for a blood factor.

149 . The product of claim 148 , wherein the blood factor is serum albumin.

150 . The product of claim 138 , wherein the monomer domains are separated by a linker.

151 . The product of claim 150 , wherein the monomer domains are separated by a peptide linker.

152 . The product of claim 151 , wherein the linker is between 4 to 12 amino acids long.

153 . The product of claim 138 , wherein the product comprises a first monomer domain that binds a first molecule and a second monomer domain that binds a second molecule.

154 . The product of claim 153 , wherein the first and second molecules are different.

155 . The product of claim 154 , wherein the first and second molecules are different copies of the same molecule.

156 . The product of claim 138 , wherein the product comprises two monomer domains, each monomer domain having a binding specificity for a different site on a first molecule.

157 . The product of claim 157 , wherein each of the two monomer domains have a binding specificity for a different binding site on the first molecule.

158 . The product of claim 138 , wherein the product comprises at least three monomer domains.

159 . The product of claim 138 , wherein the product comprises four monomer domains.

160 . The product of claim 138 , wherein a polypeptide comprises the at least four monomer domains.

161 . A product comprising at least two monomer domains, wherein at least one monomer domain is non-naturally occurring, and wherein each domain is:

a. 25-50 amino acids long and comprises at least one disulfide bond; or

b. 25-50 amino acids long and is derived from an extracellular protein; or

c. 25-50 amino acids and binds to a protein target; or

d. 35-50 amino acids long.

162 . The product of claim 161 , wherein each domain is 25-50 amino acids long and comprises at least one disulfide bond.

163 . The product of claim 161 , wherein each domain is 25-50 amino acids and binds to a protein target.

164 . The product of claim 161 , wherein each domain is 25-50 amino acids long and is derived from an extracellular protein.

165 . The product of claim 161 , wherein each domain is 35-50 amino acids long.

166 . The product of claim 165 , wherein each domain is 35-45 amino acids long.

167 . The product of claim 161 , wherein more than one of the monomer domains is a non-naturally-occurring monomer domain.

168 . The product of claim 161 , wherein each of the monomer domains is a non-naturally-occurring monomer domain.

169 . The product of claim 161 , wherein each of the monomer domains binds calcium.

170 . The product of claim 161 , wherein at least one of the monomer domains is derived from an LDL-receptor class A domain.

171 . The product of claim 161 , wherein at least one of the monomer domains is derived from an EGF-like domain.

172 . The product of claim 161 , wherein at least one domain has a binding specificity for a blood factor.

173 . The product of claim 172 , wherein the blood factor is serum albumin.

174 . The product of claim 161 , wherein the monomer domains are separated by a linker.

175 . The product of claim 174 , wherein the monomer domains are separated by a peptide linker.

176 . The product of claim 175 , wherein the linker is between 4 to 12 amino acids long.

177 . The product of claim 161 , wherein the product comprises a first monomer domain that binds a first molecule and a second monomer domain that binds a second molecule.

178 . The product of claim 177 , wherein the first and second molecules are different.

179 . The product of claim 178 , wherein the first and second molecules are different copies of the same molecule.

180 . The product of claim 161 , wherein the product comprises two monomer domains, each monomer domain having a binding specificity for a different site on a first molecule.

181 . The product of claim 156 , wherein each of the two monomer domains have a binding specificity for a different binding site on the first molecule.

182 . The product of claim 161 , wherein the product comprises at least three monomer domains.

183 . The product of claim 161 , wherein the product comprises four monomer domains.

184 . The product of claim 161 , wherein a polypeptide comprises the at least two monomer domains.

185 . A product comprising at least two monomer domains, wherein at least one monomer domain is non-naturally-occurring and each monomer domain comprises at least two disulfide bonds.

186 . The product of claim 185 , wherein each monomer domain comprises at least three disulfide bonds.

187 . The product of claim 185 , wherein at least one monomer domain is derived from an extracellular protein.

188 . The product of claim 185 , wherein at least one monomer domain binds to a target protein.

189 . The product of claim 185 , wherein more than one of the monomer domains is a non-naturally-occurring monomer domain.

190 . The product of claim 185 , wherein each of the monomer domains is a non-naturally-occurring monomer domain.

191 . The product of claim 185 , wherein each of the monomer domains binds calcium.

192 . The product of claim 185 , wherein at least one of the monomer domains is derived from an LDL-receptor class A domain.

193 . The product of claim 185 , wherein at least one of the monomer domains is derived from an EGF-like domain.

194 . The product of claim 185 , wherein at least one domain has a binding specificity for a blood factor.

195 . The product of claim 194 , wherein the blood factor is serum albumin.

196 . The product of claim 185 , wherein the monomer domains are separated by a linker.

197 . The product of claim 196 , wherein the monomer domains are separated by a peptide linker.

198 . The product of claim 197 , wherein the linker is between 4 to 12 amino acids long.

199 . The product of claim 185 , wherein the product comprises a first monomer domain that binds a first molecule and a second monomer domain that binds a second molecule.

200 . The product of claim 199 , wherein the first and second molecules are different.

201 . The product of claim 200 , wherein the first and second molecules are different copies of the same molecule.

202 . The product of claim 185 , wherein the product comprises two monomer domains, each monomer domain having a binding specificity for a different site on a first molecule.

203 . The product of claim 202 , wherein each of the two monomer domains have a binding specificity for a different binding site on the first molecule.

204 . The product of claim 185 , wherein the product comprises at least three monomer domains.

205 . The product of claim 185 , wherein the product comprises four monomer domains.

206 . The product of claim 185 , wherein the product comprises the at least two monomer domains.

207 . A method for identifying a monomer domain with affinity for a molecule, the method comprising,

providing a library of monomer domains, wherein each monomer domain:

is between 30-100 amino acids;

comprises at least one disulfide bond; and

binds an ion; and

screening the library of monomer domains for affinity to a first molecule; and

identifying at least one monomer domain that binds to at least one molecule.

208 . The method of claim 207 , wherein the ion is calcium.

209 . The method of claim 207 , further comprising,

screening the library of monomer domains for affinity to a second molecule;

identifying a monomer domain that binds to a second molecule;

linking at least one monomer domain with affinity for the first molecule with at least one monomer domain with affinity for the second molecule, thereby forming a multimer with affinity for the first and the second molecules.

210 . The method of claim 207 , further comprising,

linking the identified monomer domain to a library of monomer domains to form a library of multimers, each multimer comprising at least two monomer domains;

screening the library of multimers for the ability to bind to the first molecule or a second molecule; and

identifying a multimer that binds to the first molecule or second molecule.

211 . The method of claim 210 , wherein the library of multimers is screened for the ability to bind to the first molecule.

212 . The method of claim 210 , wherein the library of multimers is screened for the ability to bind to the second molecule.

213 . A method for identifying a multimer that binds to at least one molecule, the method comprising:

providing a library of multimers, wherein each multimer comprises at least two monomer domains, and wherein at least one monomer:

is between 30-100 amino acids;

comprises a t least one disulfide bond; and

binds an ion; and

screening the library of multimers for molecule-binding multimers.

214 . The method of claim 213 , wherein the ion is calcium.

215 . A library of multimers, wherein the multimers comprise at least two monomer domains connected by a linker; and the monomer domains

are between 30-100 amino acids;

comprise a t least one disulfide bond; and

bind an ion.

216 . The library of claim 215 , wherein the ion is calcium.

Assignments (4)
CHANGE OF NAME Recorded Mar 22, 2007
From: AVIDIA, INC.
To: AMGEN MOUNTAIN VIEW, INC.
Reel/Frame 019052/0766 →
CHANGE OF NAME Recorded Mar 23, 2006
From: AVIDIA RESEARCH INSTITUTE
To: AVIDIA, INC.
Reel/Frame 017371/0910 →
TERMINATION OF PATENT SECURITY INTEREST Recorded Apr 29, 2005
From: ALLOY VENTURES 2002, L.P.; ALLOY PARTNERS 2002, L.P.; WOODY, DR. JAMES N.; STEMMER, DR. WILLEM P.C.; VAN VLASSELAER, DR. PETER; MAXYGEN, INC.
To: AVIDIA RESEARCH INSTITUTE
Reel/Frame 015963/0826 →
SECURITY AGREEMENT Recorded Dec 27, 2004
From: AVIDIA RESEARCH INSTITUTE
To: ALLOY PARTNERS 2002, L.P.; ALLOY VENTURES 2002, L.P.; WOODY, DR JAMES N; MAXYGEN, INC.; STEMMER, DR WILLLEM P.C.; VAN VLASSELAER, DR PETER
Reel/Frame 015490/0075 →